LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis
T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao Department of Urology, Qingdao Central Hospital, Qingdao, China
The article “LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis, by T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao, published in Eur Rev Med Pharmacol Sci 2019; 23 (11): 4698-4705–DOI: 10.26355/eurrev_201906_18062–PMID: 31210308” has been retracted by the authors as they state that due to a larger sample size, their new experimental results are inconsistent with the data showed in Figure 1B of the manuscript.
The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/18062
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
T. Xu, C.-L. Liu, T. Li, Y.-H. Zhang, Y.-H. Zhao
LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis
Eur Rev Med Pharmacol Sci
Year: 2022
Vol. 26 - N. 9
Pages: 3057-3057
DOI: 10.26355/eurrev_202205_28719